# A Multicenter, Double-blind, Placebo-randomized Controlled Clinical Study on the Treatment of Non-alcoholic Steatohepatitis With Tibetan Drug Langqing Atar

> **NCT06193629** · NA · UNKNOWN · sponsor: **Shupei Li** · enrollment: 150 (estimated)

## Conditions studied

- NASH

## Interventions

- **DRUG:** Lang Qingata
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT06193629
- **Lead sponsor:** Shupei Li
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-03-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2024-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06193629

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06193629, "A Multicenter, Double-blind, Placebo-randomized Controlled Clinical Study on the Treatment of Non-alcoholic Steatohepatitis With Tibetan Drug Langqing Atar". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT06193629. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*